Loading…
Loading…
IONM does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IONM and 80,000+ other tickers.
See exactly how IONM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IONM and 80,000+ other tickers.
Assure Holdings Corp., through its various subsidiaries, specializes in delivering expert technical and professional support for intraoperative neuromonitoring (IONM), predominantly during complex spine and cranial surgical procedures. The company offers a comprehensive suite of clinical and operational services, which encompass the coordination of interoperative neurophysiologists and supervising practitioners, continuous real-time neural monitoring, patient advocacy, and all necessary billing services. These offerings are designed to assist surgeons and healthcare institutions throughout…
Institutional and Insider Ownership 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and
DENVER--(BUSINESS WIRE)--Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the “Assure Convertible Debentures”). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer (“Amended Offer Letter”) as follows: (i) updates the Amended Offer Letter to reflect a change in the con.
DENVER, July 22, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on July 26, 2024 (the “Expiration Date”) unless further extended.
DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it will effect a reverse stock split (the “Reverse Stock Split”) of its shares of common stock, $0.001 par value, at a ratio of 18 (old) for 1 (new) that will become effective on July 9, 2024 at 12:01 a.m. Pacific Standard Time.
Assure (NASDAQ: IONM ) stock is soaring higher on Thursday after the neuromonitoring surgical support services company withdrew a share offering. Assure notes that it no longer plans to move forward with a proposed stock offering that was announced on May 3.